Multicenter Single-arm Pilot Study Evaluating Efficacy of Nilotinib in CML Patients With Molecular Relapse After Glivec Discontinuation Within the Context of the STIM Trials (STIM and STIM2)

Name: Multicenter Single-arm Pilot Study Evaluating Efficacy of Nilotinib in CML Patients With Molecular Relapse After Glivec Discontinuation Within the Context of the STIM Trials (STIM and STIM2)
Published: 2013
License: Public Domain

University Hospital, Bordeaux · 2013

ClinicalTrials.gov · Datasets · License: Public Domain · 2013

Open Source ↗

chronic leukemia relapse treatment

leukemia, myelogenous, chronic, bcr-abl positive, treatment, relapse, complete molecular response, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Multicenter Single-arm Pilot Study Evaluating Efficacy of Nilotinib in CML Patients With Molecular Relapse After Glivec Discontinuation Within the Context of the STIM Trials (STIM and STIM2)

Related documents